A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2.
Mona O MohsenIna BalkeSimon ZinkhanVillija ZeltinaXuelan LiuXinyue ChangPascal S KrengerKevin PlattnerZahra GharailooAnne-Cathrine S VogtGilles Sousa AugustoMarianne ZwickerSalony RoongtaDominik A RothenRomano JosiJoana J da CostaJan M SobczakAleksandra NonicLee-Anne BrandKatja NussByron MartinaDaniel E SpeiserThomas KündigGary T JenningsSenta M WaltonMonique VogelAndris ZeltinsMartin F BachmannPublished in: Allergy (2021)
Thus, the here presented VLP-based vaccine may be a good candidate for use as conventional vaccine in the long term.
Keyphrases